Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea

BACKGROUND/AIMS: Pegylated interferon (peginterferon) and ribavirin is the current standard therapy for chronic hepatitis C. The aims of this study were to evaluate the efficacy of peginterferon and ribavirin and to identify predictors of a sustained virological response (SVR) to the retreatment of...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Cho, Hyun Chin, Gwak, Geum-Youn, Paik, Yong Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Yoo, Byung Chul, Paik, Seung Woon
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2013
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782674/
https://ncbi.nlm.nih.gov/pubmed/24073317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2013.7.5.585
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы